| Jessica Michele Berdeja, MD | |
|
9225 N 3rd St, Suite 103, Phoenix, AZ 85020-2439 | |
| (602) 906-3500 | |
| (602) 906-3519 |
| Full Name | Jessica Michele Berdeja |
|---|---|
| Gender | Female |
| Speciality | Geriatric Medicine |
| Experience | 17 Years |
| Location | 9225 N 3rd St, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215190749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | A115734 (California) | Secondary |
| 207QG0300X | Family Medicine - Geriatric Medicine | 46095 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
| Beatitudes Campus | Phoenix, AZ | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Honorhealth Medical Group, Llc | 1557274057 | 224 |
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
News Archive
The cases of four transplant recipients in the U.S. who contracted HIV from a single high-risk organ donor is being investigated by the Centers for Disease Control (CDC).
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
A selection of health policy news from Texas, California, North Carolina, Missouri, Oregon and Colorado.
Jive Software, Inc. today announced that Cerner Corp., a global leader in health care technology, has expanded its use of Jive's enterprise communication and collaboration solutions. Cerner's 93,000-member community, called "uCern," uses Jive-n to enable industry-wide collaboration that helps clinicians systemically strive to improve health care delivery.
For decades, women between the ages of 21 and 69 were advised to get annual screening exams for cervical cancer. In 2009, however, accumulating scientific evidence led major guideline groups to agree on a new recommendation that women be screened less frequently: every three years rather than annually.
› Verified 1 days ago
| Entity Name | Honorhealth Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043851793 PECOS PAC ID: 1557274057 Enrollment ID: O20031119000717 |
News Archive
The cases of four transplant recipients in the U.S. who contracted HIV from a single high-risk organ donor is being investigated by the Centers for Disease Control (CDC).
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
A selection of health policy news from Texas, California, North Carolina, Missouri, Oregon and Colorado.
Jive Software, Inc. today announced that Cerner Corp., a global leader in health care technology, has expanded its use of Jive's enterprise communication and collaboration solutions. Cerner's 93,000-member community, called "uCern," uses Jive-n to enable industry-wide collaboration that helps clinicians systemically strive to improve health care delivery.
For decades, women between the ages of 21 and 69 were advised to get annual screening exams for cervical cancer. In 2009, however, accumulating scientific evidence led major guideline groups to agree on a new recommendation that women be screened less frequently: every three years rather than annually.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Michele Berdeja, MD 2500 W Utopia Rd, Suite 100, Phoenix, AZ 85027-4171 Ph: (623) 434-6200 | Jessica Michele Berdeja, MD 9225 N 3rd St, Suite 103, Phoenix, AZ 85020-2439 Ph: (602) 906-3500 |
News Archive
The cases of four transplant recipients in the U.S. who contracted HIV from a single high-risk organ donor is being investigated by the Centers for Disease Control (CDC).
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
A selection of health policy news from Texas, California, North Carolina, Missouri, Oregon and Colorado.
Jive Software, Inc. today announced that Cerner Corp., a global leader in health care technology, has expanded its use of Jive's enterprise communication and collaboration solutions. Cerner's 93,000-member community, called "uCern," uses Jive-n to enable industry-wide collaboration that helps clinicians systemically strive to improve health care delivery.
For decades, women between the ages of 21 and 69 were advised to get annual screening exams for cervical cancer. In 2009, however, accumulating scientific evidence led major guideline groups to agree on a new recommendation that women be screened less frequently: every three years rather than annually.
› Verified 1 days ago
Dr. Serena Dawn Woods-grimm, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 201 N Central Ave, Phoenix, AZ 85004 Phone: 602-221-6326 | |
Michael Devin Taylor, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2927 N 7th Ave, Peppertree - Family Medicine #3, Phoenix, AZ 85013 Phone: 602-406-3153 Fax: 602-406-4122 | |
Dr. Umar Iqbal, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2927 N 7th Ave, Peppertree Building - Window #3, Phoenix, AZ 85013 Phone: 602-406-3153 Fax: 602-406-7176 | |
Jessica Ann Wright, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-1000 | |
Meggan E Bauer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4250 E Camelback Rd Ste K100, Phoenix, AZ 85018 Phone: 602-224-9218 | |
Dr. James W. Fisher, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12450 N 32nd St Ste 3, Phoenix, AZ 85032 Phone: 602-996-0924 Fax: 602-482-2624 | |
Geoffrey Peter Radoff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 West Greenway, Suite 210, Phoenix, AZ 85023 Phone: 602-993-0200 Fax: 602-993-0207 |